GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (OTCPK:SOMNF) » Definitions » Other Stockholders Equity

SOMNF (SomnoMed) Other Stockholders Equity : $-0.00 Mil (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is SomnoMed Other Stockholders Equity?

SomnoMed's Other Stockholders Equity for the quarter that ended in Jun. 2024 was $-0.00 Mil.

SomnoMed's quarterly Other Stockholders Equity declined from Jun. 2023 ($0.00 Mil) to Dec. 2023 ($-0.00 Mil) and declined from Dec. 2023 ($-0.00 Mil) to Jun. 2024 ($-0.00 Mil).

SomnoMed's annual Other Stockholders Equity increased from Jun. 2022 ($0.00 Mil) to Jun. 2023 ($0.00 Mil) but then declined from Jun. 2023 ($0.00 Mil) to Jun. 2024 ($-0.00 Mil).


SomnoMed Other Stockholders Equity Historical Data

The historical data trend for SomnoMed's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed Other Stockholders Equity Chart

SomnoMed Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

SomnoMed Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SomnoMed Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


SomnoMed Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of SomnoMed's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


SomnoMed Business Description

Traded in Other Exchanges
Address
20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065
SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SomnoMed Headlines

From GuruFocus

Somnomed Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-15-2024

SomnoMed posts record Q4 and delivers on FY22 revenue guidance

By PRNewswire PRNewswire 07-26-2022

Half Year 2022 Somnomed Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Full Year 2023 Somnomed Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

SomnoMed's North America Q1 revenue growth leads the way

By PRNewswire PRNewswire 10-28-2022

Full Year 2019 Somnomed Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Full Year 2024 Somnomed Ltd Earnings Call Transcript

By GuruFocus Research 08-29-2024

Somnomed Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-15-2024

Full Year 2020 Somnomed Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024